Zecyte 250mg (Abiraterone Acetate Tablet) 250mg

Zecyte 250mg is an oral tablet containing abiraterone acetate, commonly prescribed to support prostate cancer treatment. This medication works by reducing hormone levels that fuel cancer growth. Ideal for patients seeking targeted therapy. Always consult a healthcare provider before use.

Strength

250mg

Pack Size

120s

Storage

Ambient

Manufacturer / TM Owner

CIPLA LTD

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Abiraterone acetate, the active ingredient in Zecyte 250mg, is primarily used in combination with other therapies to treat prostate cancer. It helps slow disease progression by blocking androgen production. This medication is often prescribed for patients who have not responded to other treatments. It may also be used in earlier stages depending on medical guidance.

Side Effects

Zecyte 250mg tablets are taken by mouth and are designed to be absorbed gradually for consistent hormone regulation. Some patients may experience mild digestive effects or fatigue during treatment. It is important to stay hydrated and follow dietary recommendations while taking this medication. Regular monitoring is advised to assess effectiveness and tolerability.

Precautions & Warnings

Store Zecyte 250mg at room temperature, away from moisture and direct light. Keep this medication out of reach of children and pets. Inform your healthcare provider about any pre-existing liver conditions before starting treatment. Avoid crushing or splitting tablets unless directed by a medical professional.

Avoid Interactions

Zecyte 250mg may interact with certain medications, including strong CYP3A4 inhibitors or inducers, which can alter its effectiveness. Grapefruit products should be avoided due to potential interaction risks. Always review your current medications with a healthcare provider to prevent adverse effects. Alcohol use should be discussed with a doctor during treatment.

Frequently Asked Questions

Zecyte 250mg is used to treat prostate cancer by reducing androgen hormone levels that promote cancer growth.

Zecyte 250mg tablets should be taken orally as prescribed, typically on an empty stomach.

Common effects may include fatigue, digestive discomfort, or joint pain. Discuss any concerns with a healthcare provider.

Zecyte 250mg is usually taken on an empty stomach for optimal absorption. Follow your doctor's specific instructions.

Long-term use should be monitored by a healthcare provider to assess benefits and manage potential risks.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.